The sale of eczema creams labeled '0 steroid' that actually contain hidden steroids reveals a serious gap in online marketplace oversight. While HSA's warning is welcome, it came only after a child suffered serious side effects. This incident raises questions about how such products can be sold for so long without detection.
Critics argue that online platforms should bear greater responsibility for vetting health-related products before listing them. The '0 steroid' claim is a common marketing tactic that deceives parents seeking natural remedies for their children. Without effective checks, consumers are left to rely on post-incident warnings.
Moreover, the boy's experience highlights the need for better public education on buying health products online. Many consumers do not know that 'steroid-free' labels are not verified and can be misleading. HSA could do more to proactively test products rather than waiting for adverse reports.
While HSA's action is a step in the right direction, it is reactive. A more robust system of pre-market screening or mandatory registration for online health products might prevent similar cases. The burden should not be solely on consumers to identify safe products.